Eczema trials recruiting in Texas

All Eczema trials nationally

Cities in Texas

Recruiting trials in Texas

• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
  NCT07277660 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Frisco, Sugar Land
• A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
  NCT07355075 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Irving
• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Frisco, San Antonio
• A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
  NCT06807281 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · Texas: San Antonio
• A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07643766 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, San Antonio, Sugar Land
• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07599813 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: San Antonio
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
  NCT05995964 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Frisco, Houston, San Antonio
• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
  NCT06389136 · Phase: Phase 3 · Ages: 18 Years to 63 Years · Sex: All (male and female) · Texas: Arlington, Austin, Bellaire, Cypress
• A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
  NCT06807268 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · Texas: San Antonio
• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
  NCT06461897 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · Texas: Arlington, El Paso, Mansfield, San Antonio
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
  NCT07037901 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Texas: Southlake
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
  NCT06241118 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Texas: Arlington, Bellaire, Dallas
• Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT06397911 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Bellaire, Webster
• Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
  NCT07645820 · Phase: Not specified · Ages: 12 Years to 89 Years · Sex: All (male and female) · Texas: Missouri City
• Flourish: Exploring the Early Infant Gut Microbiome
  NCT07333482 · Phase: Not applicable (e.g. observational or device study) · Ages: 0 Months to 3 Months · Sex: All (male and female) · Texas: Austin
• Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
  NCT07453602 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: College Station, San Antonio
• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
  NCT07660835 · Phase: Phase 2 · Ages: 6 Months to 23 Months · Sex: All (male and female) · Texas: San Antonio
• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
  NCT06947993 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Texas: Arlington, Cypress, Dallas, Houston
• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
  NCT06988605 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · Texas: Cedar Park, Dallas, Edinburg, Grapevine
• Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
  NCT06982352 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07298395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Arlington, Houston, San Antonio
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
  NCT07290803 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · Texas: Dallas, Fort Worth, Pflugerville, Sugar Land